Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu-Gang Yu

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Cell Death Discovery|July 21, 2017
MUC1 <i>O</i>-glycosylation contributes to anoikis resistance in epithelial cancer cellsTushar Piyush, Jonathan M Rhodes, Lu-Gang Yu
Biochemical Society Transactions|November 22, 2008
Lectin-epithelial interactions in the human colonJonathan M Rhodes, Barry J Campbell, Lu-Gang Yu
International Journal of Molecular Sciences|January 8, 2023
Galectin-2 in Health and DiseasesMuhammed N Negedu, Carrie A Duckworth, Lu-Gang Yu
Plos One|January 14, 2020
Serum galectins as potential biomarkers of inflammatory bowel diseasesTony B Yu, Susanna Dodd, Lu-Gang Yu, et al.
Expert Reviews in Molecular Medicine|June 15, 2026
Developing galectin-3-targeted therapeutics in diseases: three distinct galectin-3 segments for targetingPaulina Sindrewicz-Goral, Oluwatobi Adegbite, Jessie Y Yu, et al.
Plos One|March 29, 2013
Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cellsHannah Barrow, Benjamin Tam, Carrie A Duckworth, et al.
Nutrition and Cancer|January 24, 2019
Investigation of TF-binding lectins from dietary sources and SRL on proliferation and cell cycle progression in human colon HT29 and SW620 cellsShivakumar Belur, Srikanth Barkeer, Bale M Swamy, et al.
The Journal of Biological Chemistry|July 13, 2004
Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the antiproliferative lectin, jacalinLu-Gang Yu, Len C Packman, Mike Weldon, et al.
Journal of Physiology and Biochemistry|June 16, 2012
Sorcin, a potential therapeutic target for reversing multidrug resistance in cancerBei-Bei Zheng, Peng Zhang, Wei-Wei Jia, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 2, 2010
Regulation and role of organic anion-transporting polypeptides (OATPs) in drug delivery at the choroid plexusHao Zhang, Yu-Ning Song, Wei-Guo Liu, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Cell Death Discovery|July 21, 2017
MUC1 <i>O</i>-glycosylation contributes to anoikis resistance in epithelial cancer cellsTushar Piyush, Jonathan M Rhodes, Lu-Gang Yu
Biochemical Society Transactions|November 22, 2008
Lectin-epithelial interactions in the human colonJonathan M Rhodes, Barry J Campbell, Lu-Gang Yu
International Journal of Molecular Sciences|January 8, 2023
Galectin-2 in Health and DiseasesMuhammed N Negedu, Carrie A Duckworth, Lu-Gang Yu
Plos One|January 14, 2020
Serum galectins as potential biomarkers of inflammatory bowel diseasesTony B Yu, Susanna Dodd, Lu-Gang Yu, et al.
Expert Reviews in Molecular Medicine|June 15, 2026
Developing galectin-3-targeted therapeutics in diseases: three distinct galectin-3 segments for targetingPaulina Sindrewicz-Goral, Oluwatobi Adegbite, Jessie Y Yu, et al.
Plos One|March 29, 2013
Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cellsHannah Barrow, Benjamin Tam, Carrie A Duckworth, et al.
Nutrition and Cancer|January 24, 2019
Investigation of TF-binding lectins from dietary sources and SRL on proliferation and cell cycle progression in human colon HT29 and SW620 cellsShivakumar Belur, Srikanth Barkeer, Bale M Swamy, et al.
The Journal of Biological Chemistry|July 13, 2004
Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the antiproliferative lectin, jacalinLu-Gang Yu, Len C Packman, Mike Weldon, et al.
Journal of Physiology and Biochemistry|June 16, 2012
Sorcin, a potential therapeutic target for reversing multidrug resistance in cancerBei-Bei Zheng, Peng Zhang, Wei-Wei Jia, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 2, 2010
Regulation and role of organic anion-transporting polypeptides (OATPs) in drug delivery at the choroid plexusHao Zhang, Yu-Ning Song, Wei-Guo Liu, et al.
Pageof 7